PET reversed mismatch in an experimental model of subacute myocardial infarction
- PMID: 11357495
- DOI: 10.1007/s002590000471
PET reversed mismatch in an experimental model of subacute myocardial infarction
Abstract
The aim of this study was to evaluate the relationship between flow/metabolism, histology and functional follow-up in a sheep model of subacute myocardial infarction. In eight juvenile sheep, a myocardial infarction was induced by intracoronary injection of macrobeads. Left ventricular function was evaluated using echocardiography. 2-[18F]fluoro-2-deoxy-D-glucose (18F-FDG)/nitrogen-13-labelled ammonia (13NH3) positron emission tomography (PET) was performed at 6 weeks and 16 weeks after embolization. In five sheep, a dynamic carbon-11 acetate study was performed. In each animal, two regions of interest were defined on the polar map, corresponding to the embolized and the non-embolized region. After the final measurements, the hearts were processed for histological evaluation. PET revealed a moderately decreased flow and oxidative metabolism in the embolized region at 6 weeks, without significant changes at follow-up. At 6 weeks, 18F-FDG uptake in the embolized area was more severely decreased as compared to the flow index in the embolized area (P < 0.05). At 16 weeks, 18F-FDG metabolism had significantly recovered (P < 0.05). Serial echocardiography showed a persistent decrease in global and regional left ventricular function. Histology revealed a mix of micro-infarcted and viable tissue in the embolized region. In this model of subacute myocardial infarction, a PET "reversed mismatch" pattern was observed, with partial recovery of 18F-FDG uptake at follow-up. The histological counterpart of this PET pattern appears to be patchy necrosis.
Similar articles
-
PET "reversed mismatch pattern" early after acute myocardial infarction: follow-up of flow, metabolism and function.Eur J Nucl Med. 2001 Apr;28(4):466-71. doi: 10.1007/s002590100482. Eur J Nucl Med. 2001. PMID: 11357496 Clinical Trial.
-
A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction.J Nucl Med. 1999 Sep;40(9):1492-8. J Nucl Med. 1999. PMID: 10492370
-
The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection.J Nucl Med. 2010 Dec;51(12):1908-16. doi: 10.2967/jnumed.110.078469. Epub 2010 Nov 15. J Nucl Med. 2010. PMID: 21078804 Clinical Trial.
-
Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.Herz. 1994 Feb;19(1):42-50. Herz. 1994. PMID: 8150413 Review.
-
[Clinical usefulness of positron emission tomography (PET) in the evaluation of myocardial viability].Rev Esp Cardiol. 1997 Sep;50(9):605-11. doi: 10.1016/s0300-8932(97)73272-x. Rev Esp Cardiol. 1997. PMID: 9380930 Review. Spanish.
Cited by
-
Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction.Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1155-62. doi: 10.1007/s00259-013-2423-x. Epub 2013 Apr 27. Eur J Nucl Med Mol Imaging. 2013. PMID: 23624765
-
Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome.J Nucl Cardiol. 2006 Mar-Apr;13(2):244-50. doi: 10.1007/BF02971249. J Nucl Cardiol. 2006. PMID: 16580961
-
Development of myocardial microcirculation and metabolism in acute ST-elevation myocardial infarction evaluated with positron emission tomography.J Nucl Cardiol. 2005 Jan-Feb;12(1):43-54. doi: 10.1016/j.nuclcard.2004.09.018. J Nucl Cardiol. 2005. PMID: 15682365 Clinical Trial.
-
PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey.Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):3-6. doi: 10.1007/s00259-001-0677-1. Epub 2001 Nov 14. Eur J Nucl Med Mol Imaging. 2002. PMID: 11807601 Review. No abstract available.
-
Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction.J Nucl Cardiol. 2011 Aug;18(4):657-67. doi: 10.1007/s12350-011-9389-5. Epub 2011 May 13. J Nucl Cardiol. 2011. PMID: 21567283
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical